Adiuvo Investments S.A.

Warsaw Stock Exchange ADV.WA

Adiuvo Investments S.A. Current Liabilities for the year ending December 31, 2023: USD 10.94 M

Adiuvo Investments S.A. Current Liabilities is USD 10.94 M for the year ending December 31, 2023, a 50.87% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.
  • Adiuvo Investments S.A. Current Liabilities for the year ending December 31, 2022 was USD 7.25 M, a -31.03% change year over year.
  • Adiuvo Investments S.A. Current Liabilities for the year ending December 31, 2021 was USD 10.52 M, a 98.80% change year over year.
  • Adiuvo Investments S.A. Current Liabilities for the year ending December 31, 2020 was USD 5.29 M, a 114.11% change year over year.
  • Adiuvo Investments S.A. Current Liabilities for the year ending December 31, 2019 was USD 2.47 M, a -29.90% change year over year.
Key data
Date Current Liabilities Total Non-Current Liabilities Shareholders' Equity Long-Term Debt
Market news
Loading...
SV Wall Street
Warsaw Stock Exchange: ADV.WA

Adiuvo Investments S.A.

CEO Mr. Marek Jan Orlowski M.D.
IPO Date Dec. 8, 2016
Location Poland
Headquarters ul. Gen. Józefa Zajaczka 11/14
Employees 5
Sector Finance
Industries
Description

Adiuvo Investments S.A. is a venture capital firm specializing in incubation, seed, startup, early venture, and growth capital investments. The firm primarily invests in projects in the segment of medical devices, digital health, and nutraceuticals. It seeks to invest in Poland. The firm typically invests up to a maximum of €3 million ($3.35 million). It prefers to hold its investments from three up to five years. The firm makes balance sheet investments. Adiuvo Investment S.A. was founded in 2013 and is based in Warsaw, Poland.

Similar companies

SNK.WA

Sanok Rubber Company Spólka Akcyjna

USD 5.65

-0.35%

RLP.WA

Relpol S.A.

USD 1.37

-1.62%

MDG.WA

Medicalgorithmics S.A.

USD 6.47

10.44%

StockViz Staff

February 8, 2025

Any question? Send us an email